Nephros (NEPH) EBITDA Margin (2009 - 2026)
Nephros (NEPH) posted EBITDA Margin of 30.80% for Q2 2026, up 24.44 percentage points from 6.36% a year earlier and up 28.42 percentage points from the prior quarter.
Powered by 
Analysis
Nephros (NEPH) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Nephros was 11.46%, up 2.60 percentage points year-over-year; for FY2025, it came in at 6.84%, up 5.83 percentage points from FY2024.
- Annual EBITDA Margin has increased for three consecutive years, with a five-year change of +54.35 percentage points (FY2020 to FY2025).
- In prior years, Nephros' EBITDA Margin was 1.01% in FY2024 (+10.70 pp), -9.69% in FY2023 (+30.25 pp), -39.94% in FY2022 (-12.67 pp) and -27.27% in FY2021 (+20.24 pp).
- The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q3 2010.
- On a year-over-year basis, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +9.68 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2023, with a gain of 60.58 percentage points; the weakest was Q1 2022, with a drop of 30.44 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 2.38% (Q1 2026), 1.06% (Q4 2025) and 7.30% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.20 Bn | 235.84 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 185.80 Bn | 160.26 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 162.65 Bn | 142.30 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.57 Bn | 135.86 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 132.16 Bn | 97.68 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 119.74 Bn | 105.93 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.30 Bn | 59.73 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 61.94 Bn | 45.15 Bn | 1.35 Bn | 20.05% |
| 9 | Agilent Technologies | 48.79 Bn | 41.68 Bn | 1.04 Bn | 27.16% |
| 10 | Nephros | 35.98 Mn | 17.32 Mn | 3.29 Mn | 9.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.48% |
| Jun 30, 2026 | 30.80% |
| Mar 31, 2026 | 2.38% |
| Dec 31, 2025 | 1.06% |
| Sep 30, 2025 | 7.30% |
| Jun 30, 2025 | 6.36% |
| Mar 31, 2025 | 12.43% |
| Dec 31, 2024 | 9.10% |
| Sep 30, 2024 | 6.79% |
| Jun 30, 2024 | -8.67% |
| Mar 31, 2024 | -4.71% |
| Dec 31, 2023 | -18.38% |
| Sep 30, 2023 | -4.17% |
| Jun 30, 2023 | -11.00% |
| Mar 31, 2023 | -6.82% |
| Dec 31, 2022 | -24.94% |
| Sep 30, 2022 | -50.10% |
| Jun 30, 2022 | -25.75% |
| Mar 31, 2022 | -67.39% |
| Dec 31, 2021 | -23.26% |
API Access
Nephros EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NEPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();